|1.||Tonkin, Katia: 1 article (01/2007)|
|2.||Doerkson, Courtney: 1 article (01/2007)|
|3.||Mercer, John: 1 article (01/2007)|
|4.||Kumar, Piyush: 1 article (01/2007)|
|5.||McEwan, Alexander J B: 1 article (01/2007)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/2007 - "An improved automated synthesis of [18F]FES has been developed and the integrity of this product has been validated by long term stability studies and clinical PET imaging studies in ER+ breast cancer patients. "
01/01/2007 - "Clinical production, stability studies and PET imaging with 16-alpha-[18F]fluoroestradiol ([18F]FES) in ER positive breast cancer patients."
01/01/2007 - "[18F]FES then becomes a dependable tracer for the evaluation and management of breast cancer patients. "
04/01/1997 - "The clinically useful breast cancer imaging agent, 16 alpha-[18F]fluoroestradiol-17 beta ([18F]FES), was deuterated at the C-17 alpha position to lower the rate of C-17 alcohol oxidation. "
05/28/1993 - "In order to understand the structural features that might lead to an estrogen receptor (ER) based breast tumor imaging agent with improved uptake characteristics, we have synthesized several new analogs of 16 beta-fluoroestradiol (beta FES) and studied their tissue distribution in immature rats. "
01/01/1999 - "Thus in primates, SHBG may potentiate the ER-mediated uptake of [18F]FES in ER+ tumors by selectively protecting this ligand from metabolism and ensuring its delivery to receptor-containing cells. "
11/01/1999 - "Fluorine-18 16alpha-Fluoroestradiol ([18F]-FES) is a positron-emitting tracer for the estrogen receptor that is used for positron emission tomography (PET) studies of tumor tissues rich in the estrogen receptor. "
07/01/1997 - "The aim of the present study was to assess oestrogen receptors in human meningiomas with 16alpha[l8F]fluoro-17beta-oestradiol ([18F]FES) and positron emission tomography (PET). "
07/01/1997 - "With this purpose in mind, we measured the regional brain uptake of [18F]FES in six patients with a neuroradiological and histological diagnosis of meningioma, comparing the in vivo PET data with the immunohistological analysis of oestrogen receptors performed on formalin-fixed, paraffin-embedded tissue obtained at surgery. "
|3.||Sex Hormone-Binding Globulin